A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
7 Mar 2023
Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes
Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).
18 Aug 2015
Clarification to a previous issue
14 Dec 2010
Members invited to take survey on specialty choice satisfactionACP receives grant from ABIM Foundation to improve care transitionsRate ACP's mobile website
8 Mar 2011
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
22 Nov 2022
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
1 Mar 2023
ACP's Quality Improvement (QI) Network is recruiting practices to enroll in ACPNet: Diabetes, a QI initiative that provides physicians free access to PQRSwizard, ABIM-approved MOC practice performance (part IV) credit, and ACP's Practice Advisor (formerly the Medical Home Builder).
8 Oct 2013
Weekly home INR testing comparable to monthly clinic testing
26 Oct 2010
Risk for incident diabetes is significantly higher in patients with nonfunctional adrenal tumors than in those without, and the term “nonfunctional” may minimize the potential contribution of adrenal hormone secretion to cardiometabolic risk, researchers said.
2 Aug 2016
This week's quiz asks readers about management of diabetes mellitus in a 78-year-old woman who resides in a nursing home.
7 Feb 2012